These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6391145)

  • 1. MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Sordillo PP; Cheng EW
    Am J Clin Oncol; 1984 Oct; 7(5):529-33. PubMed ID: 6391145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
    Smith FP; Hoth DF; Levin B; Karlin DA; MacDonald JS; Woolley PV; Schein PS
    Cancer; 1980 Nov; 46(9):2014-8. PubMed ID: 7427908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of 5-fluorouracil, mitomycin C, and methyl CCNU in inoperable adenocarcinoma of pancreas.
    Vaughn C; Chapman J; Chinn B; Ward D; Groshko G; Maniscalco B; Reznik S; Piper D
    Am J Clin Oncol; 1989 Feb; 12(1):49-52. PubMed ID: 2492142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
    Oster MW; Gray R; Panasci L; Perry MC
    Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-fluorouracil, adriamycin, and mitomycin in the treatment of adenocarcinoma of unknown primary.
    Goldberg RM; Smith FP; Ueno W; Ahlgren JD; Schein PS
    J Clin Oncol; 1986 Mar; 4(3):395-9. PubMed ID: 3754004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary treatment of regional and disseminated pancreatic cancer with hexamethylmelamine, mitomycin C and 5-fluorouracil infusion.
    Bruckner HW; Kalman J; Spigelman M; Gorbaty MI; Butwell N; Storch J; McKenna A
    Oncology; 1989; 46(6):366-71. PubMed ID: 2511535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung.
    Shepherd FA; Evans WK; Burkes R; Paul K; DeBoer G
    Am J Clin Oncol; 1986 Oct; 9(5):392-6. PubMed ID: 3776901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
    Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N
    Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future management.
    Smith FP; Stablein D; Korsmeyer S; Neefe J; Chun BK; Woolley PV; Schein PS
    J Clin Oncol; 1983 Jul; 1(7):413-5. PubMed ID: 6689426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
    Cunningham D; Soukop M; McArdle CS; Carter DC; Smyth JF; Allan SG; Kaye SB; Sangster G; Calman KC; Hutcheon AW
    Br J Surg; 1984 Sep; 71(9):673-6. PubMed ID: 6548166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
    Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
    Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
    Cullinan S; Moertel CG; Wieand HS; Schutt AJ; Krook JE; Foley JF; Norris BD; Kardinal CG; Tschetter LK; Barlow JF
    Cancer; 1990 May; 65(10):2207-12. PubMed ID: 2189551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
    Haim N; Epelbaum R; Cohen Y; Robinson E
    Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
    MacDonald JS; Woolley PV; Smythe T; Ueno W; Hoth D; Schein PS
    Cancer; 1979 Jul; 44(1):42-7. PubMed ID: 455263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil, doxorubicin and mitomycin C (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary.
    van der Gaast A; Verweij J; Planting AS; Stoter G
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):765-8. PubMed ID: 3383976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
    Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R
    Cancer; 1991 Sep; 68(5):965-9. PubMed ID: 1833042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.